Fused heterocycles: synthesis of some new imidazo[1,2-a]- pyridine derivatives. 2004

Birgul Ozden Kasimogullari, and Zafer Cesur
Istanbul University, Faculty of Pharmacy, Department of Pharmaceutical Chemistry, 30416, Istanbul, Turkey. okasimogullari@yahoo.com

Some new thiazolidines and spirothiazolidines derived from hydrazones of 2-methylimidazo[1,2-a]pyridine-3-carboxylic acid hydrazide, a bioisosteric derivative of isoniazid, were synthesized and characterized by analytical, IR, (1)H- and (13)C-NMR and mass spectral data. Some of the newly synthesized compounds were screened for their antimycobacterial activities. None of the tested compounds showed significant in vitro antituberculous activity at 6.25 mirog/mL (MIC rifampin 0.031 microg/mL).

UI MeSH Term Description Entries
D009169 Mycobacterium tuberculosis A species of gram-positive, aerobic bacteria that produces TUBERCULOSIS in humans, other primates, CATTLE; DOGS; and some other animals which have contact with humans. Growth tends to be in serpentine, cordlike masses in which the bacilli show a parallel orientation. Mycobacterium tuberculosis H37Rv
D011725 Pyridines Compounds with a six membered aromatic ring containing NITROGEN. The saturated version is PIPERIDINES.
D000995 Antitubercular Agents Drugs used in the treatment of tuberculosis. They are divided into two main classes: "first-line" agents, those with the greatest efficacy and acceptable degrees of toxicity used successfully in the great majority of cases; and "second-line" drugs used in drug-resistant cases or those in which some other patient-related condition has compromised the effectiveness of primary therapy. Anti-Tuberculosis Agent,Anti-Tuberculosis Agents,Anti-Tuberculosis Drug,Anti-Tuberculosis Drugs,Antitubercular Agent,Antitubercular Drug,Tuberculostatic Agent,Tuberculostatic Agents,Antitubercular Drugs,Agent, Anti-Tuberculosis,Agent, Antitubercular,Agent, Tuberculostatic,Anti Tuberculosis Agent,Anti Tuberculosis Agents,Anti Tuberculosis Drug,Anti Tuberculosis Drugs,Drug, Anti-Tuberculosis,Drug, Antitubercular

Related Publications

Birgul Ozden Kasimogullari, and Zafer Cesur
December 1993, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan,
Birgul Ozden Kasimogullari, and Zafer Cesur
January 2001, Arzneimittel-Forschung,
Birgul Ozden Kasimogullari, and Zafer Cesur
January 2001, Bollettino chimico farmaceutico,
Birgul Ozden Kasimogullari, and Zafer Cesur
January 2016, European journal of medicinal chemistry,
Birgul Ozden Kasimogullari, and Zafer Cesur
October 2002, Farmaco (Societa chimica italiana : 1989),
Birgul Ozden Kasimogullari, and Zafer Cesur
January 2015, European journal of medicinal chemistry,
Birgul Ozden Kasimogullari, and Zafer Cesur
June 1971, Bollettino chimico farmaceutico,
Copied contents to your clipboard!